Lamivudine Tablets (Shuangtao / Tongding) – 0.1?g × 14 Tablets (7 tablets × 2 blisters)

Lamivudine Tablets (Shuangtao / Tongding) – 0.1?g × 14 Tablets (7 tablets × 2 blisters)

$3.00

Lamivudine Tablets (Shuangtao/Tongding) contain 0.1g of active ingredient per tablet. This nucleoside reverse transcriptase inhibitor (NRTI) is widely utilized in HBV and HIV-related laboratory studies. Manufactured by Zhongfu Pharmaceutical Co., Ltd., China. For research use only.?Please consult staff for other specifications and uses?

EMI starting from $0.00/month - View Plans
Compare

Description

Lamivudine is a synthetic cytidine analog classified as a nucleoside reverse transcriptase inhibitor. It is commonly used in research studies involving viral DNA replication, particularly with hepatitis B and HIV. Lamivudine inhibits reverse transcriptase by terminating DNA chain elongation, providing critical insight in antiviral resistance and efficacy models.

This formulation by Zhongfu Pharmaceutical offers 0.1g per tablet, packaged as 14 tablets (7 tablets × 2 blisters), and is suitable for controlled lab testing environments.

Lamivudine Tablets Product Specifications

ParameterDetails
Product NameLamivudine Tablets (Shuangtao/Tongding)
Active IngredientLamivudine
CAS Number134678-17-4
Molecular FormulaC8H11N3O3S
Molecular Weight229.26?g/mol
Strength0.1g (100?mg) per tablet
Quantity per Box14 tablets (7 tablets × 2 blisters)
Dosage FormTablets
Approval NumberH20123047 (NMPA China)
Product Code86904180001287
ManufacturerZhongfu Pharmaceutical Co., Ltd.
Barcode6936689110720
StorageStore below 25°C, dry and protected from light
Intended UseLaboratory research only

Lamivudine Tablets Mechanism of Action

Lamivudine mimics cytidine and is incorporated into viral DNA by reverse transcriptase. This leads to chain termination and interruption of viral replication. It’s a key agent in studying HIV and HBV replication processes and drug resistance pathways.

Research Applications

  • In vitro inhibition of HBV polymerase

  • HIV reverse transcriptase analysis

  • Antiviral drug synergy testing

  • Nucleoside analog stability testing

  • Pharmacokinetic interaction modeling

Safety & Handling

  • For laboratory use only

  • Wear protective gloves and eye protection

  • Do not ingest or allow skin contact

  • Handle in accordance with institutional safety guidelines

Core  Keywords

  • Lamivudine tablets 0.1g

  • CAS 134678-17-4

  • HIV reverse transcriptase inhibitor

  • HBV antiviral compound

  • Zhongfu Pharmaceutical Lamivudine

  • Lamivudine Shuangtao Tongding

  • antiviral lab chemical

  • lamivudine research supply

  • bulk lamivudine for experiment

  • research-grade lamivudine 100mg

Research Use Disclaimer

This product is intended for laboratory research purposes only. It is not for human or animal use, and should be handled only by trained personnel in compliance with relevant safety and legal standards.

Additional information

Weight1 kg
Dimensions36 × 26 × 36 cm

Reviews

There are no reviews yet.

Be the first to review “Lamivudine Tablets (Shuangtao / Tongding) – 0.1?g × 14 Tablets (7 tablets × 2 blisters)”

Your email address will not be published. Required fields are marked *

Q1: What is the CAS number of Lamivudine?

A1: The CAS number is 134678-17-4.

Q2: Can these tablets be used in humans?

A2: No. These tablets are strictly intended for laboratory use only, not for clinical or therapeutic use.

Q3: What is the quantity per box?

A3: Each box contains 14 tablets (2 blisters of 7 tablets).

Q4: Do you provide bulk purchasing discounts?

A4: Yes. We support both retail and wholesale orders, including bulk quantities.

Q5: Do you supply the Certificate of Analysis (COA)?

A5: Yes. COA and SDS documents are available upon request.


EMI Options

Select at least 2 products
to compare